Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 3
2008 3
2009 2
2010 4
2011 3
2012 5
2013 3
2014 3
2015 7
2016 10
2017 9
2018 12
2019 14
2020 15
2021 10
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
PET/Computed Tomography in the Individualization of Treatment of Prostate Cancer.
Ceci F, Castellucci P, Graziani T, Schiavina R, Fanti S. Ceci F, et al. PET Clin. 2015 Oct;10(4):487-94. doi: 10.1016/j.cpet.2015.05.004. Epub 2015 Jul 2. PET Clin. 2015. PMID: 26384595 Review.
Choline PET/computed tomographic (CT) imaging represents the most diffused PET imaging techniques to investigate patients with prostate cancer (PCa). ...This review analyzes the value of choline PET/CT imaging in the evaluation of treatment of p …
Choline PET/computed tomographic (CT) imaging represents the most diffused PET imaging techniques to investigate patients with …
Prostate imaging: Contribution of PET PSMA and MRI.
Abecassis JP, Ghazzar N, Peyromaure M, Giraud P. Abecassis JP, et al. Cancer Radiother. 2020 Aug;24(5):423-428. doi: 10.1016/j.canrad.2020.06.002. Epub 2020 Jun 30. Cancer Radiother. 2020. PMID: 32620459 Review.
Prostate cancer is the most common malignant tumour and represents the third cause of cancer-mortality in men. ...Imaging plays a key role in all the steps of prostate cancer management. In recent years, magnetic resonance imaging (MRI) and posi …
Prostate cancer is the most common malignant tumour and represents the third cause of cancer-mortality in men. ...Imagi …
Qualitative and quantitative reproducibility of [18]fluoromethycholine PET/computed tomography in prostate cancer.
Pinto-Leite T, Tixier F, Upadhaya T, Gallais C, Perdrisot R, Cheze Le Rest C. Pinto-Leite T, et al. Nucl Med Commun. 2020 Feb;41(2):147-154. doi: 10.1097/MNM.0000000000001129. Nucl Med Commun. 2020. PMID: 31939917 Clinical Trial.
BACKGROUND: Recurrence occurs in more than 50% of prostate cancer. To be effective, treatments require precise localization of tumor cells. [F]fluoromethylcholine ([18F]FCH) PET/computed tomography (CT) is currently used to restage diseas …
BACKGROUND: Recurrence occurs in more than 50% of prostate cancer. To be effective, treatments require precise localiza …
(68)Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends.
Udovicich C, Perera M, Hofman MS, Siva S, Del Rio A, Murphy DG, Lawrentschuk N. Udovicich C, et al. Prostate Int. 2017 Dec;5(4):125-129. doi: 10.1016/j.prnil.2017.02.003. Epub 2017 Feb 24. Prostate Int. 2017. PMID: 29188197 Free PMC article. Review.
The early and accurate detection of prostate cancer is important to ensure timely management and appropriate individualized treatment. ...Novel imaging modalities using radiolabeled tracers with PSMA such as (68)Ga-PSMA-positron emission tomography …
The early and accurate detection of prostate cancer is important to ensure timely management and appropriate individualized …
Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
Goldstein J, Even-Sapir E, Ben-Haim S, Saad A, Spieler B, Davidson T, Berger R, Weiss I, Appel S, Lawrence YR, Symon Z. Goldstein J, et al. Am J Clin Oncol. 2017 Jun;40(3):256-259. doi: 10.1097/COC.0000000000000139. Am J Clin Oncol. 2017. PMID: 25319322
PURPOSE: The FDA approved C-11 choline PET/computed tomography (CT) for imaging patients with recurrent prostate cancer in 2012. ...CONCLUSIONS: These early results suggest that labeled choline PET/CT imaging performed according to current NCCN …
PURPOSE: The FDA approved C-11 choline PET/computed tomography (CT) for imaging patients with recurrent prostate …
PET Imaging of Skeletal Metastases and Its Role in Personalizing Further Management.
Mahajan A, Azad GK, Cook GJ. Mahajan A, et al. PET Clin. 2016 Jul;11(3):305-18. doi: 10.1016/j.cpet.2016.02.003. Epub 2016 Mar 23. PET Clin. 2016. PMID: 27321034 Review.
In oncology, the skeleton is one of the most frequently encountered sites for metastatic disease and thus early detection not only has an impact on an individual patient's management but also on the overall outcome. Multiparametric and multimodal hybrid PET/compu …
In oncology, the skeleton is one of the most frequently encountered sites for metastatic disease and thus early detection not only has an im …
18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels <2.00 ng/mL.
Garza D, Kandathil A, Xi Y, Subramaniam RM. Garza D, et al. Nucl Med Commun. 2021 Aug 1;42(8):907-913. doi: 10.1097/MNM.0000000000001412. Nucl Med Commun. 2021. PMID: 33741863
OBJECTIVE: To establish the detection rate of prostate cancer recurrence following definitive therapy by 18F-fluciclovine PET/computed tomography (CT) in patients with biochemical recurrence (BCR) and prostate-specific antigen (PSA …
OBJECTIVE: To establish the detection rate of prostate cancer recurrence following definitive therapy by 18F-fluciclovi …
The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.
Picchio M, Briganti A, Fanti S, Heidenreich A, Krause BJ, Messa C, Montorsi F, Reske SN, Thalmann GN. Picchio M, et al. Eur Urol. 2011 Jan;59(1):51-60. doi: 10.1016/j.eururo.2010.09.004. Epub 2010 Sep 15. Eur Urol. 2011. PMID: 20869161 Review.
CONTEXT: Choline positron emission tomography (PET)/computed tomography (CT) is a currently used diagnostic tool in restaging prostate cancer (PCa) patients with increasing prostate-specific antigen (PSA) after either radical prost …
CONTEXT: Choline positron emission tomography (PET)/computed tomography (CT) is a currently used diagnostic tool …
PET and PET-CT. State of the art and future prospects.
Fanti S, Franchi R, Battista G, Monetti N, Canini R. Fanti S, et al. Radiol Med. 2005 Jul-Aug;110(1-2):1-15. Radiol Med. 2005. PMID: 16163136 Review. English, Italian.
The exact localization of lesions may also be difficult in some cases on the basis of PET images alone. The introduction of combined PET-computed tomography (PET-CT) scanners enables the almost simultaneous acquisition of transmission and emission images, thu …
The exact localization of lesions may also be difficult in some cases on the basis of PET images alone. The introduction of combined PET …
Prostate-specific membrane antigen positron emission tomography in prostate cancer: a step toward personalized medicine.
Bouchelouche K, Choyke PL. Bouchelouche K, et al. Curr Opin Oncol. 2016 May;28(3):216-21. doi: 10.1097/CCO.0000000000000277. Curr Opin Oncol. 2016. PMID: 26967720 Free PMC article. Review.
PURPOSE OF REVIEW: Increasing attention is being given to personalized medicine in oncology, where therapies are tailored to the particular characteristics of the individual cancer patient. In recent years, there has been greater focus on prostate-specific me …
PURPOSE OF REVIEW: Increasing attention is being given to personalized medicine in oncology, where therapies are tailored to the particular …
92 results